Spyre Therapeutics Inc
(NAS:SYRE)
$
87.25
+0.17 (+0.2%)
Market Cap: 7.69 Bil
Enterprise Value: 6.69 Bil
PE Ratio: 0
PB Ratio: 8.05
GF Score: 26/100 Spyre Therapeutics Inc (SYRE) Transcripts
- 1